TIVICAY
Identification of Tivicay
| No description |
Google image searchProduct monograph
Active ingredient
dolutegravir (dolutegravir sodium), 5 MG
DIN: 02511517
Dosage form(s): TABLET FOR SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
Date: 31-JAN-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AJ — Integrase inhibitors (ATC, ATC/DDD)
- J05AJ03 — DOLUTEGRAVIR (ATC/DDD)
Reference brand drug: Tivicay
